We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Survey: Most Orthopedic Specialists Want Access to Vioxx, Looser Drug Approval Process
Survey: Most Orthopedic Specialists Want Access to Vioxx, Looser Drug Approval Process
January 31, 2007
A newly published survey suggests that orthopedists want to see a shorter FDA drug approval process and a return to the market of Vioxx, despite the agency’s concerns with the drug.